Background: AgNOR pleomorphism has been widely used for its diagnostic importance in differentiating premalignant and malignant lesions of different human neoplasms. However, an evaluation of its potential for discriminating cases of high-risk squamous intraepithelial lesions of the cervix (SIL) has been rarely attempted. Aim: The tumor marker potential of AgNOR pleomorphism counts was assessed by correlating high and low mean counts in low-grade SIL (LSIL) cases with persistence or regression of the lesion and HPV positivity. Materials and Methods: The 115 LSIL cases selected for the study were registered from the ongoing cervical cancer screening of the rural population of Lucknow West. Silver nitrate staining for AgNOR counts and HPV DNA testing were done in all 115 cases. Results: The AgNOR counts in the 115 LSIL cases revealed low counts in 92 and high counts in 23 cases. Follow-up, available in 107 cases, revealed persistence of the lesion in 21 of the 23 cases with high counts and in 4 of the 84 cases with low counts. HPV positivity showed a strong correlation with high counts. Persistence of LSIL was also more frequent with high AgNOR counts and in HPV-positive cases. Conclusions: The study showed a correlation of high mean AgNOR counts with HPV positivity and persistence of LSIL.

1.
Cardillo
MR
.
AgNOR counts are useful in cervical smears
.
Diagn Cytopathol
.
1992
;
8
(
3
):
208
10
.
[PubMed]
8755-1039
2.
Darne
JF
,
Polacarz
SV
,
Sheridan
E
,
Anderson
D
,
Ginsberg
R
,
Sharp
F
.
Nucleolar organiser regions in adenocarcinoma in situ and invasive adenocarcinoma of the cervix
.
J Clin Pathol
.
1990
Aug
;
43
(
8
):
657
60
.
[PubMed]
0021-9746
3.
Edelson
OV
,
Marilla
DN
.
Silver staining methods for nucleolar organizer regions in cervical smears
.
Diagn Cytopathol
.
1996
;
16
:
497
9
.8755-1039
4.
Egan
M
,
Freeth
M
,
Crocker
J
.
Intraepithelial neoplasia, human papilloma virus infection and argyrophilic nucleoprotein in cervical epithelium
.
Histopathology
.
1988
Nov
;
13
(
5
):
561
7
.
[PubMed]
0309-0167
5.
Rowlands
DC
.
Nucleolar organising regions in cervical intraepithelial neoplasia
.
J Clin Pathol
.
1988
Nov
;
41
(
11
):
1200
2
.
[PubMed]
0021-9746
6.
Calore
EE
,
Shirata
NK
,
Shih
LW
,
Cavaliere
MJ
,
de Siqueira
M
.
Silver staining method for nucleolar organizer regions in cervical smears
.
Diagn Cytopathol
.
1997
Jun
;
16
(
6
):
497
9
.
[PubMed]
8755-1039
7.
Prathiba
D
,
Kuruvilla
S
.
Value of AgNORS in premalignant and malignant lesions of the cervix
.
Indian J Pathol Microbiol
.
1995
Jan
;
38
(
1
):
11
6
.
[PubMed]
0377-4929
8.
Misra
JS
,
Das
V
,
Srivastava
AN
,
Singh
U
,
Singh
M
.
AgNOR counts in cervical smears under normal and other cytopathologic conditions
.
Anal Quant Cytol Histol
.
2005
Dec
;
27
(
6
):
337
40
.
[PubMed]
0884-6812
9.
Misra
JS
,
Chhavi
,
Singh
M
,
Srivastava
AN
,
Das
V
.
Assessment of potential of AgNOR counts as tumor marker in cervical carcinogenesis
.
Diagn Cytopathol
.
2008
Mar
;
36
(
3
):
194
5
.
[PubMed]
8755-1039
10.
Srivastava
A
,
Srivastava
S
,
Bansal
C
,
Misra
J
.
Diagnostic importance of AgNOR pleomorphism in cervical carcinogenesis
.
Ecancermedicalscience
.
2013
;
7
:
287
.
[PubMed]
1754-6605
11.
Tosi
P
,
Cintorino
M
,
Santopietro
R
,
Lio
R
,
Barbini
P
,
Ji
H
, et al
Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV). Quantitative data and cytokeratin expression
.
Pathol Res Pract
.
1992
Oct
;
188
(
7
):
866
73
.
[PubMed]
0344-0338
12.
Khot
KP
,
Kotak
KJ
,
Bagri-Manjrekar
K
,
Alex
S
,
Choudhari
SS
.
Pleomorphism of argyrophilic nucleolar organizer regions in oral submucous fibrosis and oral squamous cell carcinoma
.
J Nat Sci Biol Med
.
2015
Aug
;
6
(
1
Suppl 1
):
S35
9
.
[PubMed]
0976-9668
13.
Elangovan
T
,
Mani
NJ
,
Malathi
N
.
Agyrophillic nucleolar organizer regions in inflammatory, pre-malignant and malignant oral lesions:A quantitative and qualitative assessment
.
Indian J Dent Res
.
2008
;
19
(
2
):
142
6
. 0970-9290
14.
Sowmya
GV
,
Nahar
P
,
Astekar
M
,
Agarwal
H
&
Singh
MP
.
Analysis of silver binding nucleolar organizer regions in exfoliative cytology smears of potentially malignant and malignant oral lesions.
Biotechnic and Histochem.
2017
: 92(2).
15.
Madhavin
BE
,
Ravishanker
V
.
Study of AgNOR counts cytology smears of breast lesions
.
Indian J Basic Appl Med Res
.
2016
;
5
(
4
):
380
6
.2250-284X
16.
Basher
,
ES
,
Hasan
,
AN
and
Awad
,
MH
.Micronuclei and AgNOR and biomarker in fine needle aspiration cytology of breast tumor.Amer.J.Res.Comm.
2016
:4(1)
17.
Mahajan
D
,
Singh
V
,
Gupta
YL
.
Evaluation of AgNORs in FNAC smears and tissue sections in benign and malignant breast lesions
.
Ind. J. Pathol. and Oncol.
2016
;
3
(
2
):
174
81
.
18.
Kaushik
R
,
Singh
D
,
Gulati
A
and Sharma VK Evaluation of AgNORs in gallbladder lesions IJRMS.
2017
:5(3).
19.
Dhingra
H
and Satyawati. Silver stained nucleolar organizer regions in non-neoplastic and neoplastic of endometrium.
Sch.J.Appl.Med.Sci.
2016
;
4
(
1
):
47
51
.
20.
Alarcón-Romero
LC
,
Illades-Aguiar
B
,
Flores-Alfaro
E
,
Terán-Porcayo
MA
,
Antonio-Véjar
V
,
Reyes-Maldonado
E
.
AgNOR polymorphism association with squamous intraepithelial lesions and invasive carcinoma with HPV infection
.
Salud Publica Mex
.
2009
Mar-Apr
;
51
(
2
):
134
40
.
[PubMed]
0036-3634
21.
Bethesda system of reporting vaginal: cervical cytological diagnosis
.
Acta Cytol
.
1993
;
57
(
2
):
115
20
.
[PubMed]
0001-5547
22.
Khanna
AK
,
Giri
AK
,
Khanna
A
,
Kumar
M
.
Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors
.
J Surg Oncol
.
2001
Dec
;
78
(
4
):
273
8
.
[PubMed]
0022-4790
23.
Cabrini
RL
,
Schwint
AE
,
Mendez
A
,
Femopase
F
,
Lanfranchi
H
,
Itoiz
ME
.
Morphometric study of nucleolar organizer regions in human oral normal mucosa, papilloma and squamous cell carcinoma
.
J Oral Pathol Med
.
1992
Jul
;
21
(
6
):
275
9
.
[PubMed]
0904-2512
24.
Pelusi
G
,
Trerè
D
,
Formelli
G
,
Rinaldi
AM
,
Derenzini
M
.
AgNOR protein quantity of cervical smears correlates with that of histological sections in cervical intraepithelial neoplasia
.
Eur J Histochem
.
1997
;
41
(
2
):
105
10
.
[PubMed]
1121-760X
25.
Singh
M
,
Prasad
S
,
Kalra
N
,
Singh
U
,
Shukla
Y
.
Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry
.
Oncology
.
2006
;
71
(
5-6
):
411
6
.
[PubMed]
0030-2414
26.
Palaoro
LA
,
Blanco
AM
,
Gamboni
M
,
Rocher
AE
,
Rotenberg
RG
.
Usefulness of ploidy, AgNOR and immunocytochemistry for differentiating benign and malignant cells in serous effusions
.
Cytopathology
.
2007
Feb
;
18
(
1
):
33
9
.
[PubMed]
0956-5507
27.
Thickett
KM
,
Griffin
NR
,
Griffiths
AP
,
Wells
M
.
A study of nucleolar organizer regions in cervical intraepithelial neoplasia and human papillomavirus infection
.
Int J Gynecol Pathol
.
1989
;
8
(
4
):
331
9
.
[PubMed]
0277-1691
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.